1 December 2024 false No description of principal activity Taxfiler 2024.6 15266451 business:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 15266451 2024-11-30 15266451 2024-12-01 2025-11-30 15266451 business:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 15266451 business:FilletedAccounts 2024-12-01 2025-11-30 15266451 2025-11-30 15266451 2024-11-30 15266451 core:WithinOneYear 2025-11-30 15266451 core:WithinOneYear 2024-11-30 15266451 core:ShareCapital core:PreviouslyStatedAmount 2025-11-30 15266451 core:ShareCapital core:PreviouslyStatedAmount 2024-11-30 15266451 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-11-30 15266451 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-11-30 15266451 core:PreviouslyStatedAmount 2025-11-30 15266451 core:PreviouslyStatedAmount 2024-11-30 15266451 business:SmallEntities 2024-12-01 2025-11-30 15266451 business:Director1 2024-12-01 2025-11-30 15266451 countries:EnglandWales 2024-12-01 2025-11-30 15266451 business:RegisteredOffice 2024-12-01 2025-11-30 15266451 business:OrdinaryShareClass1 2024-12-01 2025-11-30 15266451 business:OrdinaryShareClass1 2023-11-07 2024-11-30 15266451 2023-11-07 2024-11-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 15266451 (England and Wales)
Cardiac ANB Limited Unaudited accounts for the year ended 30 November 2025
Cardiac ANB Limited Unaudited accounts Contents
Page
Statement of financial position
3
Notes to the accounts
4
- 2 -
Cardiac ANB Limited Statement of financial position as at 30 November 2025
2025
2024
Notes
£
£
Current assets
Debtors
4
173
112
Cash at bank and in hand
9,552
7,675
9,725
7,787
Creditors: amounts falling due within one year
5
(4,214)
(4,292)
Net current assets
5,511
3,495
Net assets
5,511
3,495
Capital and reserves
Called up share capital
6
2
2
Profit and loss account
5,509
3,493
Shareholders' funds
5,511
3,495
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 17 August 2026 and were signed on its behalf by
A Boulemden Director Company Registration No. 15266451
- 3 -
Cardiac ANB Limited Notes to the Accounts for the year ended 30 November 2025
1
Statutory information
Cardiac ANB Limited is a private company, limited by shares, registered in England and Wales, registration number 15266451. The registered office is 8 Marella Close, Edwalton, Nottingham, Nottinghamshire, NG12 4LJ, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
Financial instruments
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.
4
Debtors
2025
2024
£
£
Amounts falling due within one year
Other debtors
173
112
- 4 -
Cardiac ANB Limited Notes to the Accounts for the year ended 30 November 2025
5
Creditors: amounts falling due within one year
2025
2024
£
£
Taxes and social security
707
2,288
Other creditors
2,024
154
Accruals
1,483
1,850
4,214
4,292
6
Share capital
2025
2024
£
£
Allotted, called up and fully paid:
2 Ordinary shares of £1 each
2
2
7
Average number of employees
During the year the average number of employees was 1 (2024: 1).
- 5 -